Adriana Valdelamar, Fernando De La Hoz, Ricardo Sánchez
{"title":"[孤独是癌症患者死亡率的预测因素,一项队列研究]。","authors":"Adriana Valdelamar, Fernando De La Hoz, Ricardo Sánchez","doi":"10.7705/biomedica.7150","DOIUrl":null,"url":null,"abstract":"<p><p>Introduction. Some studies have indicated that loneliness may be associated with an increased risk of mortality in cancer patients, as it can weaken treatment response and the immune system, and promote harmful behaviors, worsening the prognosis and increasing the likelihood of death. Addressing loneliness in public health is essential to provide social support and improve outcomes in cancer patients.\nObjective. To obtain an estimator of the unwanted loneliness-mortality association.\nMaterials and methods. We followed a prospective cohort of 400 patients for two years (exposure=loneliness levels; outcome=mortality; sociodemographic and clinical control variables were included). A parametric survival model (log normal) was used.\nResults. The cohort had a median survival of 20.2 months and a mortality rate of 3.2 deaths/100 patient-months (95% CI: 2.8 to 3.7). The survival model found the following time ratios (TR): moderate level/low level: TR=0.55; 95% CI: 0.39 to 0.77; moderately high level/low level: TR=0.62; 95% CI: 0.41 to 0.93; high level/low level: TR=1.17; 95% CI: 0.31 to 4.42.\nConclusion. Compared to patients with low levels of loneliness, patients with moderate or moderately high levels reach death more quickly (statistically significant TRs, adjusted for the effect of other variables in the model); this highlights the need for interventions to mitigate loneliness and promote social support in patients having cancer.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"44 Sp. 1","pages":"119-138"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418832/pdf/","citationCount":"0","resultStr":"{\"title\":\"Loneliness as a predictor of mortality in cancer patients, a cohort study\",\"authors\":\"Adriana Valdelamar, Fernando De La Hoz, Ricardo Sánchez\",\"doi\":\"10.7705/biomedica.7150\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Introduction. Some studies have indicated that loneliness may be associated with an increased risk of mortality in cancer patients, as it can weaken treatment response and the immune system, and promote harmful behaviors, worsening the prognosis and increasing the likelihood of death. Addressing loneliness in public health is essential to provide social support and improve outcomes in cancer patients.\\nObjective. To obtain an estimator of the unwanted loneliness-mortality association.\\nMaterials and methods. We followed a prospective cohort of 400 patients for two years (exposure=loneliness levels; outcome=mortality; sociodemographic and clinical control variables were included). A parametric survival model (log normal) was used.\\nResults. The cohort had a median survival of 20.2 months and a mortality rate of 3.2 deaths/100 patient-months (95% CI: 2.8 to 3.7). The survival model found the following time ratios (TR): moderate level/low level: TR=0.55; 95% CI: 0.39 to 0.77; moderately high level/low level: TR=0.62; 95% CI: 0.41 to 0.93; high level/low level: TR=1.17; 95% CI: 0.31 to 4.42.\\nConclusion. Compared to patients with low levels of loneliness, patients with moderate or moderately high levels reach death more quickly (statistically significant TRs, adjusted for the effect of other variables in the model); this highlights the need for interventions to mitigate loneliness and promote social support in patients having cancer.</p>\",\"PeriodicalId\":101322,\"journal\":{\"name\":\"Biomedica : revista del Instituto Nacional de Salud\",\"volume\":\"44 Sp. 1\",\"pages\":\"119-138\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11418832/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomedica : revista del Instituto Nacional de Salud\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7705/biomedica.7150\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedica : revista del Instituto Nacional de Salud","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7705/biomedica.7150","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
导言。一些研究表明,孤独可能与癌症患者死亡风险的增加有关,因为孤独会削弱对治疗和免疫系统的反应,并助长有害行为,这可能会恶化预后,增加这些患者死亡的可能性。在公共卫生中解决孤独问题对于为癌症患者提供社会支持和改善预后至关重要。目标。估算癌症患者不必要的孤独感与死亡率之间的关系。材料和方法。对 400 名患者进行为期两年的前瞻性队列随访(暴露=孤独程度;结果=死亡时间)。社会人口学变量和临床控制变量也包括在内。采用参数生存模型(对数正态)。研究结果组群的中位生存期为 20.2 个月,死亡率为每 100 个患者月 3.2 例死亡(95% CI 2.8 至 3.7)。生存模型中发现了以下生存比(RT):中低水平:RT=0.55,95% CI 0.39 至 0.77;中高水平-低水平:RT=0.62,95% CI 0.41 至 0.93;高水平-低水平:RT=1.17,95% CI 0.31 至 4.42。结论与低度孤独感患者相比,中度或中度高度孤独感患者的死亡速度更快(在对模型中其他变量的影响进行调整后,RT具有显著的统计学意义)。这表明,减轻癌症患者孤独感和促进社会支持的干预措施是有用的。
Loneliness as a predictor of mortality in cancer patients, a cohort study
Introduction. Some studies have indicated that loneliness may be associated with an increased risk of mortality in cancer patients, as it can weaken treatment response and the immune system, and promote harmful behaviors, worsening the prognosis and increasing the likelihood of death. Addressing loneliness in public health is essential to provide social support and improve outcomes in cancer patients.
Objective. To obtain an estimator of the unwanted loneliness-mortality association.
Materials and methods. We followed a prospective cohort of 400 patients for two years (exposure=loneliness levels; outcome=mortality; sociodemographic and clinical control variables were included). A parametric survival model (log normal) was used.
Results. The cohort had a median survival of 20.2 months and a mortality rate of 3.2 deaths/100 patient-months (95% CI: 2.8 to 3.7). The survival model found the following time ratios (TR): moderate level/low level: TR=0.55; 95% CI: 0.39 to 0.77; moderately high level/low level: TR=0.62; 95% CI: 0.41 to 0.93; high level/low level: TR=1.17; 95% CI: 0.31 to 4.42.
Conclusion. Compared to patients with low levels of loneliness, patients with moderate or moderately high levels reach death more quickly (statistically significant TRs, adjusted for the effect of other variables in the model); this highlights the need for interventions to mitigate loneliness and promote social support in patients having cancer.